Home News Update Konica Minolta Business Innovation Center Secures Exclusive Servicing Partnership with Knightscope

Konica Minolta Business Innovation Center Secures Exclusive Servicing Partnership with Knightscope

by Imaging Solution Bureau

Konica Minolta Business Innovation Center (BIC) announced an exclusive multi-year servicing partnership and sizable strategic investment in Knightscope, developer of fully autonomous security robots.

Konica Minolta has been a trusted partner and investor in Knightscope since 2014. The renewed, exclusive commitment continues this strategic alignment. Konica Minolta continues to leverage its existing expertise and assets to expand robotic servicing and support, including onsite installation, maintenance and break/fix services for the Knightscope machines. The relationship, one of several Konica Minolta robotic partnerships, demonstrates the commitment Konica Minolta has towards helping scale innovative companies by servicing and support, sales, supplying components, and design consulting.

“As an early partner of Knightscope, Konica Minolta is thrilled to have supported their tremendous success by providing resources to help them scale across the United States. At the Konica Minolta Business Innovation Center, we look for promising partners like Knightscope with whom we can grow and leverage the full scale of our global expertise,” says Ekta Sahasi, vice president, Business Innovation Center, and managing director, Research and Development, Konica Minolta.

Knightscope develops fully autonomous robots that provide a commanding but friendly physical security presence. Known as Autonomous Data Machines (ADMs), the K3, K5, and future K7 use an array of sensors to gather important real-time, on-site data. The data is then processed with advanced anomaly detection software to determine and alert authorities if there is concern or threat on premise. Knightscope is deploying with 24 clients in 5 states. Clients include major malls, hospitals, corporate campuses, warehouses as well as a pharmaceutical company and a stadium

You may also like

Leave a Comment

Copyright @2021 All Right Reserved – Designed and Developed by RoyMediative